Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice
Mikołaj Ogrodnik(Austrian Cluster for Tissue Regeneration), Diana Jurk(Mayo Clinic in Florida), Nicola Neretti(Brown University), Nathan K. LeBrasseur(WinnMed), Christine Inman(Mayo Clinic), Bettina M. Weigand(Mayo Clinic in Florida), Tamar Tchkonia(Cedars-Sinai Medical Center), Edward Fielder(Newcastle University), Ayush Patel(Mayo Clinic in Florida), Stella Victorelli(Mayo Clinic in Florida), Shane A. Evans(Brown University), Hanna Salmonowicz(Mayo Clinic in Florida), David B. Allison(Indiana University Bloomington), Tamar Pirtskhalava(Mayo Clinic in Florida), Kurt O. Johnson(Mayo Clinic), Thomas von Zglinicki(Newcastle University), Stephanie Dickinson(Indiana University Bloomington), Patrick Krüger(Newcastle Hospitals - Campus for Ageing and Vitality), Yi Zhu(University of Macau), Azucena Rocha(Brown University), João F. Passos(Newcastle University), Marissa Schafer(WinnMed), James L. Kirkland(Cedars-Sinai Medical Center)
Cited by 410
Related Papers
The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
|Aging Cell|2015|2.4k
Cellular senescence mediates fibrotic pulmonary disease
|Nature Communications|2017|1.5k
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
|EBioMedicine|2019|1.2k
Cellular senescence drives age-dependent hepatic steatosis
|Nature Communications|2017|1k